{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:05:49Z","timestamp":1789070749737,"version":"build-2803163510"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Regeneron Pharmaceutical"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0220156","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T17:32:16Z","timestamp":1564680736000},"page":"e0220156","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacological inhibition of NPY receptors illustrates dissociable features of experimental colitis in the mouse DSS model: Implications for preclinical evaluation of efficacy in an inflammatory bowel disease model"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0213-6759","authenticated-orcid":true,"given":"Henry H.","family":"Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz A.","family":"Cortes-Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Eckersdorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn E.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3949-1877","authenticated-orcid":true,"given":"Susan D.","family":"Croll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,8,1]]},"reference":[{"issue":"9573","key":"ref1","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"DC Baumgart","year":"2007","journal-title":"Lancet"},{"issue":"898","key":"ref2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/pmj.76.898.473","article-title":"Mucins and inflammatory bowel disease","volume":"76","author":"T Shirazi","year":"2000","journal-title":"Postgrad Med J"},{"key":"ref3","unstructured":"Specian RD, Oliver MG. Functional biology of intestinal goblet cells. (0002\u20139513 (Print))."},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/jcmm.12193","article-title":"Inflammatory cytokines promote growth of intestinal smooth muscle cells by induced expression of PDGF-Rbeta","volume":"18","author":"DG Nair","year":"2014","journal-title":"Journal of cellular and molecular medicine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.15585\/mmwr.mm6542a3","article-title":"Prevalence of Inflammatory Bowel Disease Among Adults Aged \u226518 Years\u2014United States, 2015","volume":"65","author":"ZE Dahlhamer JM","year":"2016","journal-title":"MMWR Morbidity and mortality weekly report"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10787-014-0207-y","article-title":"Animal models of inflammatory bowel disease: a review","volume":"22","author":"N Goyal","year":"2014","journal-title":"Inflammopharmacology"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jcmgh.2015.01.006","article-title":"Experimental Models of Inflammatory Bowel Diseases","volume":"1","author":"P Kiesler","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"Suppl 3","key":"ref8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2036.1997.tb00813.x","article-title":"Review article: How relevant to human inflammatory bowel disease are current animal models of intestinal inflammation?","volume":"11","author":"RB Sartor","year":"1997","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"G763","DOI":"10.1152\/ajpgi.00004.2013","article-title":"The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases","volume":"305","author":"V Valatas","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"718617","DOI":"10.1155\/2012\/718617","article-title":"Dextran sodium sulphate colitis mouse model: traps and tricks","volume":"2012","author":"M Perse","year":"2012","journal-title":"J Biomed Biotechnol"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4196\/kjpp.2014.18.4.279","article-title":"A review on chemical-induced inflammatory bowel disease models in rodents","volume":"18","author":"PK Randhawa","year":"2014","journal-title":"Korean J Physiol Pharmacol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/jpet.112.198796","article-title":"Novel Insights on the Effect of Nicotine in a Murine Colitis Model","volume":"344","author":"SD AlSharari","year":"2013","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"e32084","DOI":"10.1371\/journal.pone.0032084","article-title":"Dextran Sodium Sulfate (DSS) Induces Colitis in Mice by Forming Nano-Lipocomplexes with Medium-Chain-Length Fatty Acids in the Colon","volume":"7","author":"H Laroui","year":"2012","journal-title":"PLoS ONE"},{"issue":"8","key":"ref14","first-page":"576","article-title":"Ulcerative Colitis and Crohn\u2019s Disease","volume":"39","author":"K Gohil","year":"2014","journal-title":"Pharmacy and Therapeutics"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ibd.20753","article-title":"Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-Induced Colitis","volume":"15","author":"P Alex","year":"2009","journal-title":"Inflammatory bowel diseases"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1365-2249.1999.00878.x","article-title":"Interferon-gamma (IFN-\u03b3)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice","volume":"116","author":"F Obermeier","year":"1999","journal-title":"Clinical and Experimental Immunology"},{"issue":"9","key":"ref17","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/gut.2009.197822","article-title":"Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome","volume":"59","author":"C Bauer","year":"2010","journal-title":"Gut"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1007\/BF01303184","article-title":"Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin","volume":"38","author":"SNS Murthy","year":"1993","journal-title":"Digestive diseases and sciences"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.2353\/ajpath.2006.051021","article-title":"Differential Angiogenic Regulation of Experimental Colitis","volume":"169","author":"JH Chidlow","year":"2006","journal-title":"The American journal of pathology"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1023\/A:1019629013945","article-title":"Differential Susceptibility of Multidrug Resistance Protein-1 Deficient Mice to DSS and TNBS-Induced Colitis","volume":"47","author":"T Ten Hove","year":"2002","journal-title":"Digestive diseases and sciences"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.autneu.2006.11.005","article-title":"The autonomic nervous system and inflammatory bowel disease","volume":"133","author":"CT Taylor","year":"2007","journal-title":"Autonomic neuroscience: basic & clinical"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1440-1681.2009.05242.x","article-title":"Clinical and experimental evidence of sympathetic neural dysfunction during inflammatory bowel disease","volume":"36","author":"L Boisse","year":"2009","journal-title":"Clinical and experimental pharmacology & physiology"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10620-008-0424-6","article-title":"Autonomic dysfunctions in patients with inflammatory bowel disease in clinical remission","volume":"54","author":"P Sharma","year":"2009","journal-title":"Digestive diseases and sciences"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MCG.0b013e3181b2682a","article-title":"Impact of autonomic dysfunction on inflammatory bowel disease","volume":"44","author":"AN Ananthakrishnan","year":"2010","journal-title":"Journal of clinical gastroenterology"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"R224","DOI":"10.1152\/ajpregu.00442.2005","article-title":"Sympathetic overactivity in active ulcerative colitis: effects of clonidine","volume":"290","author":"R Furlan","year":"2006","journal-title":"American Journal of Physiology\u2014Regulatory, Integrative and Comparative Physiology"},{"key":"ref26","first-page":"7","article-title":"Neuronal populations in the submucous plexus of the human colon","volume":"166","author":"CH Hoyle","year":"1989","journal-title":"Journal of anatomy"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00590","article-title":"The Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel Disease","volume":"6","author":"M Di Giovangiulio","year":"2015","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"ref28","first-page":"143","article-title":"XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors","volume":"50","author":"MC Michel","year":"1998","journal-title":"Pharmacological reviews"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1084\/jem.20051971","article-title":"A fundamental bimodal role for neuropeptide Y1 receptor in the immune system","volume":"202","author":"J Wheway","year":"2005","journal-title":"J Exp Med"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"e3304","DOI":"10.1371\/journal.pone.0003304","article-title":"Targeted deletion of neuropeptide Y (NPY) modulates experimental colitis","volume":"3","author":"B Chandrasekharan","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"G550","DOI":"10.1152\/ajpgi.00182.2004","article-title":"Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling","volume":"288","author":"H Hassani","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00384-010-0964-z","article-title":"Amelioration of dextran sulfate sodium-induced colitis by neuropeptide Y antisense oligodeoxynucleotide","volume":"25","author":"XH Pang","year":"2010","journal-title":"International journal of colorectal disease"},{"issue":"1\u20132","key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2004.05.009","article-title":"Reduced tissue immigration of monocytes by neuropeptide Y during endotoxemia is associated with Y2 receptor activation","volume":"155","author":"H Nave","year":"2004","journal-title":"J Neuroimmunol"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"e13066","DOI":"10.1371\/journal.pone.0013066","article-title":"Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data","volume":"5","author":"I Kupershmidt","year":"2010","journal-title":"PLOS ONE"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ibd.20848","article-title":"Pain and Inflammatory Bowel Disease","volume":"15","author":"K Bielefeldt","year":"2009","journal-title":"Inflammatory bowel diseases"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/j.1572-0241.2005.00256.x","article-title":"Narcotic Use in Patients with Crohn's Disease","volume":"100","author":"RK Cross","year":"2005","journal-title":"The American journal of gastroenterology"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/cphy.c130055","article-title":"Central Nervous System Control of Gastrointestinal Motility and Secretion and Modulation of Gastrointestinal Functions","volume":"4","author":"KN Browning","year":"2014","journal-title":"Comprehensive Physiology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.npep.2015.09.005","article-title":"The role of the neuropeptide Y (NPY) family in the pathophysiology of inflammatory bowel disease (IBD)","volume":"55","author":"M El-Salhy","year":"2016","journal-title":"Neuropeptides"},{"issue":"9","key":"ref39","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00384-010-0964-z","article-title":"Amelioration of dextran sulfate sodium-induced colitis by neuropeptide Y antisense oligodeoxynucleotide","volume":"25","author":"XH Pang","year":"2010","journal-title":"Int J Colorectal Dis"},{"issue":"8","key":"ref40","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.peptides.2011.06.007","article-title":"Neuropeptide Y modulates functions of inflammatory cells in the rat: distinct role for Y1, Y2 and Y5 receptors","volume":"32","author":"K Mitic","year":"2011","journal-title":"Peptides"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jneuroim.2008.01.012","article-title":"Neuropeptide Y receptor-specifically modulates human neutrophil function","volume":"195","author":"S Bedoui","year":"2008","journal-title":"Journal of neuroimmunology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0220156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T16:13:00Z","timestamp":1721578380000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0220156"}},"subtitle":[],"editor":[{"given":"Hiroyasu","family":"Nakano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0220156","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,1]]}}}